Blackston Financial Advisory Group, LLC Bristol Myers Squibb CO Transaction History

Blackston Financial Advisory Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $5,949 - $6,745	-124 Reduced 2.91%	4,143 $224,000
Q4 2023 Jan 17, 2024	SELL	$48.48 - $57.85 $37,281 - $44,486	-769 Reduced 15.27%	4,267 $218,000
Q3 2023 Jan 26, 2024	BUY	$57.89 - $64.73 $19,566 - $21,878	338 Added 7.92%	4,605 $267,000
Q2 2023 Jul 19, 2023	SELL	$63.71 - $70.74 $14,079 - $15,633	-221 Reduced 4.2%	5,036 $322,000
Q1 2023 Apr 21, 2023	SELL	$65.71 - $74.53 $4,074 - $4,620	-62 Reduced 1.17%	5,257 $364,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $25,543 - $30,246	-373 Reduced 6.55%	5,319 $383,000
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $53 - $31,427	409 Added 7.74%	5,692 $441,000
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $55,626 - $61,264	-766 Reduced 12.66%	5,283 $397,000
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $86,317 - $103,502	1,404 Added 30.23%	6,049 $358,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $249,111 - $290,405	4,645 New	4,645 $290,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Blackston Financial Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Blackston Financial Advisory Group, LLC with notifications on news.